Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Raw Materials (2025 - 2026)

Updated

Outlook Therapeutics (OTLK) recorded Raw Materials of $2.34 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), unchanged from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Raw Materials (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics reported Raw Materials of $2.35 million.

  • Quarterly Raw Materials has ranged from $2.34 million in fiscal Q2 2026 to $2.35 million in fiscal Q1 2026 over the past five years.
  • Per Business Quant, the preceding three fiscal quarters came in at $2.34 million (Q2 2026), $2.35 million (Q1 2026) and $2.35 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.34 Mn
Mar 31, 2026 2.34 Mn
Dec 31, 2025 2.35 Mn
Sep 30, 2025 2.35 Mn
API Access

Outlook Therapeutics Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=OTLK&period=max&api_key=YOUR_API_KEY